Vitali Stanevich

613 citations
9 papers · 470 indexed · h-index 9
Topics
Cancer-related gene regulation (3 papers)Ubiquitin and proteasome pathways (2 papers)Epigenetics and DNA Methylation (2 papers)
Partner nations
United StatesChina

In The Last Decade

Vitali Stanevich

9 papers receiving 469 citations

Peers

Vitali Stanevich
Comparison fields: 5 of 70
  • Molecular Biology 342
  • Oncology 95
  • Cell Biology 54
  • Pathology and Forensic Medicine 44
  • Cancer Research 42
Replace Yuki Kitaoka with:
Yuki Kitaoka Japan
Sandra Timm Pearce United States
Choong Won Kim South Korea
Omar S. Khan United States
Meiguo Xin United States
Roberto Jun Arai Brazil
Dennis M. Kraichely United States
Amélie Heneman-Masurel France
C.J. Apolito United States
Jennifer Schulte United States
Vitali Stanevich relative to Yuki Kitaoka Japan Yuki Kitaoka's profile →
Citations per field
00.5×10×14.7×
Yuki Kitaoka · 1×
Citations per year

Countries citing papers authored by Vitali Stanevich

Since Specialization
Citations

This map shows the geographic impact of Vitali Stanevich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vitali Stanevich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vitali Stanevich more than expected).

Fields of papers citing papers by Vitali Stanevich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vitali Stanevich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vitali Stanevich. The network helps show where Vitali Stanevich may publish in the future.

Co-authorship network of co-authors of Vitali Stanevich

This figure shows the co-authorship network connecting the top 25 collaborators of Vitali Stanevich. A scholar is included among the top collaborators of Vitali Stanevich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vitali Stanevich. Vitali Stanevich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
#WorkIndexed citations
1 30
2 33
3 41
4 17
5 56
6 76
7 53
8 56
9 108

About Vitali Stanevich

Vitali Stanevich is a scholar working on Molecular Biology, Pharmacology and Health, Toxicology and Mutagenesis, having authored 9 papers that have together received 470 indexed citations. Recurring topics across this work include Cancer-related gene regulation (3 papers), Ubiquitin and proteasome pathways (2 papers) and Epigenetics and DNA Methylation (2 papers). The work is most often cited by research in Molecular Biology (342 citations), Oncology (95 citations) and Aging (6 citations). Vitali Stanevich has collaborated with scholars based in United States and China. Frequent co-authors include Yongna Xing, Kenneth A. Satyshur, Li Jiang, Feng Guo, Nathan Wlodarchak, Philip D. Jeffrey, Zhu Li, M. F. SEMMELHACK, Yongfeng Li and Aiping Zheng. Their work appears in journals such as Nature Communications, Molecular Cell and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026